Help to interpret the results
The page contains two contents:
General: this table lists the KO entries and their description specific to this pathway, and provides their frequencies in Morganella psychrotolerans and in the whole dataset.
Profile + homologs: the distribution of the Kegg entries of FoxO signaling pathway Kegg pathway is displayed here. Given a Kegg entry and a genome, a red box indicates that one or more loci have been annotated with, while a green box indicates that no locus/loci has(have) been annotated with it, but it/they is/are part of an Orthologous group in which other members have been annotated with that Kegg entry, so it is likely that this copy(ies) also performs this Kegg function.
Check the composition of the FoxO signaling pathway pathway
| KO | Description | #in this genome | All occurrences |
|---|---|---|---|
| K00922 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] | 0 | 0 |
| K01084 | glucose-6-phosphatase [EC:3.1.3.9] | 0 | 0 |
| K01110 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] | 0 | 0 |
| K01596 | phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32] | 0 | 0 |
| K02206 | cyclin-dependent kinase 2 [EC:2.7.11.22] | 0 | 0 |
| K02649 | phosphoinositide-3-kinase regulatory subunit alpha/beta/delta | 0 | 0 |
| K02833 | GTPase HRas | 0 | 0 |
| K03099 | son of sevenless | 0 | 0 |
| K03781 | catalase [EC:1.11.1.6] | 1 | 7 |
| K03875 | F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) | 0 | 0 |
| K04288 | sphingosine 1-phosphate receptor 1 | 0 | 0 |
| K04293 | sphingosine 1-phosphate receptor 4 | 0 | 0 |
| K04357 | epidermal growth factor | 0 | 0 |
| K04361 | epidermal growth factor receptor [EC:2.7.10.1] | 0 | 0 |
| K04364 | growth factor receptor-bound protein 2 | 0 | 0 |
| K04365 | B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04366 | RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04368 | mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] | 0 | 0 |
| K04369 | mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] | 0 | 0 |
| K04371 | mitogen-activated protein kinase 1/3 [EC:2.7.11.24] | 0 | 0 |
| K04388 | TGF-beta receptor type-2 [EC:2.7.11.30] | 0 | 0 |
| K04389 | tumor necrosis factor ligand superfamily member 6 | 0 | 0 |
| K04402 | growth arrest and DNA-damage-inducible protein | 0 | 0 |
| K04411 | serine/threonine kinase 4 | 0 | 0 |
| K04440 | mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24] | 0 | 0 |
| K04441 | p38 MAP kinase [EC:2.7.11.24] | 0 | 0 |
| K04456 | RAC serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04467 | inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] | 0 | 0 |
| K04468 | nemo like kinase [EC:2.7.11.24] | 0 | 0 |
| K04498 | E1A/CREB-binding protein [EC:2.3.1.48] | 0 | 0 |
| K04501 | mothers against decapentaplegic homolog 4 | 0 | 0 |
| K04503 | G1/S-specific cyclin-D1 | 0 | 0 |
| K04526 | insulin | 0 | 0 |
| K04527 | insulin receptor [EC:2.7.10.1] | 0 | 0 |
| K04564 | superoxide dismutase, Fe-Mn family [EC:1.15.1.1] | 2 | 14 |
| K04603 | metabotropic glutamate receptor 1 | 0 | 0 |
| K04674 | TGF-beta receptor type-1 [EC:2.7.11.30] | 0 | 0 |
| K04685 | cyclin-dependent kinase inhibitor 2B | 0 | 0 |
| K04692 | signal transducer and activator of transcription 3 | 0 | 0 |
| K04721 | tumor necrosis factor ligand superfamily member 10 | 0 | 0 |
| K04728 | serine-protein kinase ATM [EC:2.7.11.1] | 0 | 0 |
| K05072 | interleukin 7 receptor | 0 | 0 |
| K05087 | insulin-like growth factor 1 receptor [EC:2.7.10.1] | 0 | 0 |
| K05405 | interleukin 6 | 0 | 0 |
| K05443 | interleukin 10 | 0 | 0 |
| K05459 | insulin-like growth factor 1 | 0 | 0 |
| K05868 | G2/mitotic-specific cyclin-B1 | 0 | 0 |
| K06276 | 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1] | 0 | 0 |
| K06623 | cyclin-dependent kinase inhibitor 2D | 0 | 0 |
| K06624 | cyclin-dependent kinase inhibitor 1B | 0 | 0 |
| K06625 | cyclin-dependent kinase inhibitor 1A | 0 | 0 |
| K06631 | polo-like kinase 1 [EC:2.7.11.21] | 0 | 0 |
| K06643 | E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27] | 0 | 0 |
| K07187 | insulin receptor substrate 2 | 0 | 0 |
| K07191 | MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 4 | 0 | 0 |
| K07198 | 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.31] | 0 | 0 |
| K07199 | 5'-AMP-activated protein kinase, regulatory beta subunit | 0 | 0 |
| K07200 | 5'-AMP-activated protein kinase, regulatory gamma subunit | 0 | 0 |
| K07201 | forkhead box protein O1 | 0 | 0 |
| K07209 | inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] | 0 | 0 |
| K07298 | serine/threonine-protein kinase 11 [EC:2.7.11.1] | 0 | 0 |
| K07827 | GTPase KRas | 0 | 0 |
| K07828 | GTPase NRas | 0 | 0 |
| K08336 | ubiquitin-like protein ATG12 | 0 | 0 |
| K08341 | GABA(A) receptor-associated protein | 0 | 0 |
| K08845 | A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K08861 | polo-like kinase 2 [EC:2.7.11.21] | 0 | 0 |
| K08862 | polo-like kinase 3 [EC:2.7.11.21] | 0 | 0 |
| K08863 | polo-like kinase 4 [EC:2.7.11.21] | 0 | 0 |
| K08960 | casein kinase 1, epsilon [EC:2.7.11.1] | 0 | 0 |
| K09385 | forkhead box protein G | 0 | 0 |
| K09408 | forkhead box protein O3 | 0 | 0 |
| K10146 | cyclin G2 | 0 | 0 |
| K10151 | G1/S-specific cyclin-D2 | 0 | 0 |
| K10305 | F-box protein 25/32 | 0 | 0 |
| K10628 | V(D)J recombination-activating protein 1 [EC:2.3.2.27] | 0 | 0 |
| K10988 | recombination-activating protein 2 | 0 | 0 |
| K11411 | NAD-dependent protein deacetylase sirtuin 1 [EC:2.3.1.286] | 0 | 0 |
| K11431 | [histone H3]-lysine4 N-methyltransferase [EC:2.1.1.364] | 0 | 0 |
| K11434 | type I protein arginine methyltransferase [EC:2.1.1.319] | 0 | 0 |
| K11838 | ubiquitin carboxyl-terminal hydrolase 7 [EC:3.4.19.12] | 0 | 0 |
| K12358 | forkhead box protein O4 | 0 | 0 |
| K13302 | serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1] | 0 | 0 |
| K13303 | serum/glucocorticoid-regulated kinase 2 [EC:2.7.11.1] | 0 | 0 |
| K13304 | serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1] | 0 | 0 |
| K13375 | transforming growth factor beta-1 | 0 | 0 |
| K13376 | transforming growth factor beta-2 | 0 | 0 |
| K13377 | transforming growth factor beta-3 | 0 | 0 |
| K15010 | homer | 0 | 0 |
| K15464 | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 | 0 | 0 |
| K15618 | B-cell lymphoma 6 protein | 0 | 0 |
| K16172 | insulin receptor substrate 1 | 0 | 0 |
| K16332 | retinoblastoma-like protein 2 | 0 | 0 |
| K16341 | Bcl-2-like protein 11 | 0 | 0 |
| K17445 | insulin receptor substrate 3 | 0 | 0 |
| K17446 | insulin receptor substrate 4 | 0 | 0 |
| K17845 | krueppel-like factor 2 | 0 | 0 |
| K17847 | forkhead box protein O6 | 0 | 0 |
| K17848 | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 | 0 | 0 |
| K21770 | G2/mitotic-specific cyclin-B2 | 0 | 0 |
| K21771 | G2/mitotic-specific cyclin-B3 | 0 | 0 |
| K23605 | mothers against decapentaplegic homolog 3 | 0 | 0 |